{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:51:04Z","timestamp":1790142664944,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.pharep.2017.03.012","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T13:15:11Z","timestamp":1489842911000},"page":"943-952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pharmacodynamic and pharmacokinetic interactions between simvastatin and diazepam in rats"],"prefix":"10.1007","volume":"69","author":[{"given":"Wojciech","family":"S\u0142upski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Trocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rutkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2017.03.012_bib0005","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1161\/01.CIR.99.16.2192","article-title":"Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy","volume":"99","author":"Rozanski","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pharep.2017.03.012_bib0010","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1001\/archinte.160.13.1913","article-title":"The influence of anxiety and depression on outcomes of patients with coronary artery disease","volume":"160","author":"Januzzi","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.pharep.2017.03.012_bib0015","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1124\/mol.59.3.442","article-title":"Molecular targets for the myorelaxant action of diazepam","volume":"59","author":"Crestani","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharep.2017.03.012_bib0020","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/0006-2952(89)90314-6","article-title":"Comparative drug metabolism of diazepam in hepatocytes isolated from man, rat, monkey and dog","volume":"38","author":"Seddon","year":"1989","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pharep.2017.03.012_bib0025","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1586\/erc.11.106","article-title":"Current status of statin therapy for stroke prevention","volume":"9","author":"Sett","year":"2011","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.pharep.2017.03.012_bib0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","author":"Yusuf","year":"2002","journal-title":"Comment Lancet"},{"key":"10.1016\/j.pharep.2017.03.012_bib0035","doi-asserted-by":"crossref","first-page":"20607","DOI":"10.3390\/ijms151120607","article-title":"Molecular mechanisms underlying the effects of statins in the central nervous system","volume":"15","author":"McFarland","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharep.2017.03.012_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000328773","article-title":"Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of losartan and its main metabolite EXP-3174 in rats: possible role of CYP3A4 and P-gp inhibition by HMG-CoA reductase inhibitors","volume":"88","author":"Yang","year":"2011","journal-title":"Pharmacology"},{"key":"10.1016\/j.pharep.2017.03.012_bib0045","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/phrs.1993.1127","article-title":"Effects of simvastatin and pravastatin on 6 beta-hydroxycortisol excretion, a potential marker of cytochrome P-450 3A","volume":"28","author":"Horsmans","year":"1993","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharep.2017.03.012_bib0050","first-page":"1","article-title":"Investigation of the induction properties of HMG-CoA reductase inhibitors cerivastatin, simvastatin, atorvastatin pravastatin, and fluvastatin in cultures of primary human hepatocytes","volume":"38","author":"Ferguson","year":"2006","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.pharep.2017.03.012_bib0055","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1124\/dmd.110.033886","article-title":"Profiling induction of cytochrome p450 enzyme activity by statins using a new liquid chromatography-tandem mass spectrometry cocktail assay in human hepatocytes","volume":"38","author":"Feidt","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharep.2017.03.012_bib0060","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.lfs.2004.06.022","article-title":"Pharmacokinetic and pharmacodynamic interactions between simvastatin and diltiazem in patients with hypercholesterolemia and hypertension","volume":"76","author":"Watanabe","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.pharep.2017.03.012_bib0065","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0090-9556(24)02979-9","article-title":"Strain differences in diazepam metabolism at its three metabolic sites in sprague-dawley, brown norway, dark agouti, and wistar strain rats","volume":"32","author":"Saito","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharep.2017.03.012_bib0070","first-page":"413","article-title":"Behavioral interactions of simvastatin and fluoxetine in tests of anxiety and depression","volume":"8","author":"Santos","year":"2012","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.pharep.2017.03.012_bib0075","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/npp.2013.284","article-title":"Simvastatin treatment highlights a new role for the isoprenoid\/cholesterol biosynthetic pathway in the modulation of emotional reactivity and cognitive performance in rats","volume":"39","author":"Segatto","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharep.2017.03.012_bib0080","first-page":"3764","article-title":"Role of statins in animal models of anxiety in Normo-cholesterolemic rats","volume":"5","author":"Pemminati","year":"2012","journal-title":"J Pharm Res"},{"key":"10.1016\/j.pharep.2017.03.012_bib0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.expneurol.2008.11.016","article-title":"High dose of simvastatin induces hyperlocomotive and anxiolytic-like activities: the association with the up-regulation of NMDA receptor binding in the rat brain","volume":"216","author":"Wang","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pharep.2017.03.012_bib0090","first-page":"39","article-title":"Acute antidepressant and anxiolytic effects of simvastatin and its mechanisms in rats","volume":"17","author":"Kilic","year":"2012","journal-title":"Neurosciences"},{"key":"10.1016\/j.pharep.2017.03.012_bib0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-6147(00)88973-7","article-title":"Use of the elevated plus maze in the search for novel anxiolytic agents","volume":"16","author":"Dawson","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharep.2017.03.012_bib0100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1590\/S0100-879X1997000300002","article-title":"Animal models of anxiety: an ethological perspective","volume":"30","author":"Rodgers","year":"1997","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.pharep.2017.03.012_bib0105","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF02245598","article-title":"Effects of benzodiazepine receptor partial inverse agonists in the elevated plus maze test of anxiety in the rat","volume":"121","author":"Cole","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharep.2017.03.012_bib0110","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1523\/JNEUROSCI.5274-10.2011","article-title":"Calcitonin gene-related peptide in the bed nucleus of the stria terminalis produces an anxiety-like pattern of behavior and increases neural activation in anxiety-related structures","volume":"31","author":"Sink","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharep.2017.03.012_bib0115","doi-asserted-by":"crossref","first-page":"e20945","DOI":"10.1371\/journal.pone.0020945","article-title":"Simvastatin prevents dopaminergic neurodegeneration in experimental parkinsonian models: the association with anti-inflammatory responses","volume":"6","author":"Yan","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharep.2017.03.012_bib0120","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/sj.bjp.0706106","article-title":"High doses of simvastatin upregulate dopamine D1 and D2 receptor expression in the rat prefrontal cortex: possible involvement of endothelial nitric oxide synthase","volume":"144","author":"Wang","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2017.03.012_bib0125","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1006\/exnr.1999.7283","article-title":"NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum","volume":"161","author":"Zeevalk","year":"2000","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pharep.2017.03.012_bib0130","doi-asserted-by":"crossref","first-page":"9576","DOI":"10.1073\/pnas.90.20.9576","article-title":"Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated","volume":"90","author":"Cepeda","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl. 2","key":"10.1016\/j.pharep.2017.03.012_bib0135","first-page":"S102","article-title":"24S-hydroxycholesterol: a marker of brain cholesterol metabolism","volume":"36","author":"L\u00fctjohann","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pharep.2017.03.012_bib0140","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1007\/BF03216281","article-title":"Lowering of plasma cholesterol levels in animals by lovastatin and simvastatin","volume":"40","author":"Chao","year":"1991","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.pharep.2017.03.012_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2004.02.083","article-title":"Simvastatin prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion and protein tyrosine nitration in mice","volume":"1037","author":"Selley","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.pharep.2017.03.012_bib0150","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1590\/S0103-64402006000400001","article-title":"Influence of simvastatin on bone regeneration of tibial defects and blood cholesterol level in rats","volume":"17","author":"Anbinder","year":"2006","journal-title":"Braz Dent J"},{"key":"10.1016\/j.pharep.2017.03.012_bib0155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neubiorev.2012.10.005","article-title":"Neurosteroids, stress and depression: potential therapeutic opportunities","volume":"37","author":"Zorumski","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharep.2017.03.012_bib0160","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1471-4159.2011.07474.x","article-title":"Inhibition of neuronal cholesterol biosynthesis with lovastatin leads to impaired synaptic vesicle release even in the presence of lipoproteins or geranylgeraniol","volume":"119","author":"Mailman","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharep.2017.03.012_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2012.12.002","article-title":"Pharmacodynamic potentiation of antiepileptic drugs\u2019 effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA\/2 mice","volume":"70","author":"Russo","year":"2013","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharep.2017.03.012_bib0170","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/0091270009332435","article-title":"Effects of statins on the pharmacokinetics of midazolam in healthy volunteers","volume":"49","author":"Kokudai","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.pharep.2017.03.012_bib0175","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.clpt.2005.11.016","article-title":"Comparison of midazolam and simvastatin as cytochrome P450 3A probes","volume":"79","author":"Chung","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.pharep.2017.03.012_bib0180","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF03191168","article-title":"Effects of simvastatin on the pharmacokinetics of verapamil and its main metabolite, norverapamil, in rats","volume":"34","author":"Choi","year":"2009","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.pharep.2017.03.012_bib0185","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/sj.bjp.0703920","article-title":"HMG-CoA reductase inhibitors and P-glycoprotein modulation","volume":"132","author":"Bogman","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2017.03.012_bib0190","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2174\/1389200033489262","article-title":"Transcriptional regulation of cytochrome p450 2B genes by nuclear receptors","volume":"4","author":"Wang","year":"2003","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.pharep.2017.03.012_bib0195","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/bdd.249","article-title":"Equally potent inhibitors of cholesterol synthesis in human hepatocytes have distinguishable effects on different cytochrome P450 enzymes","volume":"21","author":"Cohen","year":"2000","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.pharep.2017.03.012_bib0200","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.3109\/00498259609046742","article-title":"Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: role of CYP2B6, 2C19 and the 3A subfamily","volume":"26","author":"Ono","year":"1996","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pharep.2017.03.012_bib0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00008571-199312000-00003","article-title":"Cytochrome P450 mediated metabolism of diazepam in human and rat: involvement of human CYP2C in N-demethylation in the substrate concentration-dependent manner","volume":"3","author":"Yasumori","year":"1993","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.pharep.2017.03.012_bib0210","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1517\/17425250903207002","article-title":"Impact of rat P450 genetic polymorphism on diazepam metabolism","volume":"5","author":"Sakai","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.pharep.2017.03.012_bib0215","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00232-008-9117-5","article-title":"Benzodiazepine-mediated structural changes in the multidrug transporter P-glycoprotein: an intrinsic fluorescence quenching analysis","volume":"223","author":"Lima","year":"2008","journal-title":"J Membr Biol"},{"key":"10.1016\/j.pharep.2017.03.012_bib0220","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejps.2009.01.009","article-title":"Effects of acid and lactone forms of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on the induction of MDR1 expression and function in LS180 cells","volume":"37","author":"Yamasaki","year":"2009","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.pharep.2017.03.012_bib0225","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-444-53630-3.00008-7","article-title":"Neurosteroids endogenous role in the human brian and therapeutic potentials","volume":"186","author":"Reddy","year":"2010","journal-title":"Prog Brain Res"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S173411401630336X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S173411401630336X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:02Z","timestamp":1752611822000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2017.03.012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S173411401630336X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2017.03.012","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacodynamic and pharmacokinetic interactions between simvastatin and diazepam in rats","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2017.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}